Gen AI Innovations Weekly: Exploring the Top Generative AI Developments
Join us as we explore the latest trends and unveil game-changing technologies that are shaping the future of AI-driven solutions.
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 25
Join us as we explore the latest trends and unveil game-changing technologies that are shaping the future of AI-driven solutions.
Tegria, a leading healthcare services and solutions company, has appointed Jay Sultan as its new Chief Data and Analytics Officer.
Qlik®, a renowned leader in data integration, analytics, and artificial intelligence (AI), continues to drive significant business outcomes across various industries with its innovative AI solutions.
Happiest Minds has strategically invested in a dedicated Generative AI business unit, solidifying its position as a 'Niche & Established' player in Gen-AI Engineering Services.
MaxisIT, a prominent provider of clinical data analytics platforms, has launched SMART Optimizer, heralded as the industry’s first AI-enabled system for optimizing clinical trials.
These applications aim to enhance payer productivity and elevate member experiences, aligning with Pager's commitment to revolutionize healthcare through innovation.
Named Franklin™, this innovative platform is tailored to address the unique challenges faced by government entities, offering customizable AI capabilities while ensuring data privacy, security, and seamless integration.
The panel discussion underscored the critical role of generative AI in driving business innovation and efficiency across sectors.
As businesses and individuals alike race to harness the power of this transformative technology, a common theme emerges – the drive to unlock new levels of efficiency, creativity, and personalization.
While challenges exist in budgeting, measuring ROI, and scaling implementation, a strategic approach can unlock substantial value across functions
The newly introduced solutions—AI Assistant, AI Scribe, and AI Support—promise to streamline various aspects of practice management and healthcare delivery.
As we delve into these highlights, we'll explore how these innovations are shaping the landscape of technology, driving global AI adoption, and paving the way for a future driven by AI-driven insights and intelligent automation.
This partnership seeks to enhance Abridge's mission to improve clinician and patient lives through generative AI technologies.
I believe the landscape of technologies will continue to evolve, alongside shifting focuses.
CrowdStrike, a leading cybersecurity company, and NVIDIA, a pioneer in AI computing, have announced a strategic collaboration aimed at advancing cybersecurity through the integration of generative AI capabilities.
Cognizant announces a strategic collaboration with NVIDIA to leverage generative AI (gen AI) technology through the NVIDIA BioNeMo platform.
With the introduction of the new NVIDIA Blackwell GPU platform on AWS, customers can access cutting-edge infrastructure and services to unlock the full potential of generative AI technologies.
These innovations aim to revolutionize data center design, simulation, drug discovery, and therapeutic design.
Bayer has unveiled a pioneering pilot program introducing an expert Generative AI (GenAI) system aimed at enhancing efficiency and empowering agronomists in their daily endeavors.
TrialAssure, a prominent pharmaceutical technology provider dedicated to advancing clinical trial disclosure and transparency, has introduced TrialAssure ANONYMIZE® 3.0, its latest iteration of data and document anonymization software.